Breast Cancer and the Environment - Report from the IOM

A report from the Institute of Medicine (IOM)Breast Cancer and the Environment: A Life Course Approach, examines the existing literature about breast cancer risk posed by various environmental factors, highlights actions that offer potential to reduce risk, and recommends key areas for future research. The report, sponsored by Susan G. Komen for the Cure, was released on December 7th with a press release and report briefing. The findings were then presented formally in a plenary session at the 2011 San Antonio Breast Cancer Symposium. According to the IOM report summary, the evaluators conclude:

“Women may have some opportunities to reduce their risk of breast cancer through personal actions, such as avoiding unnecessary medical radiation throughout life, avoiding use of estrogen–progestin hormone therapy, avoiding smoking, limiting alcohol consumption, increasing physical activity, and, for postmenopausal breast cancer, minimizing weight gain. In addition to applying a life-course approach to studies of breast cancer, research recommendations include developing improved tools for epidemiologic research and testing of chemicals and other substances, developing effective preventive interventions, developing better approaches to modeling breast cancer risks, and improving communication about breast cancer risks.”

In other words, for a cool million the report told us what we already know. There are a few known risk factors that account for a relatively small percentage of breast cancer cases; it’s hard to study environmental causation; more research is needed across the life span; and, we need better methods to test agents that may be contributing to breast cancer and to explore the effects of combined exposures. In addition to restating these existing conclusions, the report may have done more to mystify than to clarify.

Genetics alone cannot explain the rise in breast cancer incidence in the United States, which has been increasing about 1 percent per year for the past sixty years and rose by more than 40 percent between 1973 and 1998. Only 30 percent of breast cancer cases are attributed to the generally accepted risk factors, and notably, the longer immigrant women live in the U.S. the more likely they are to get breast cancer. International, national, state, and community-based organizations have been evaluating the role of environmental exposures for decades.

The U.S. National Toxicology Program (NTP) has identified substances and exposures that are known or suspected to cause cancer, including: naturally occurring exposures (ultraviolet light, radon gas, infectious agents, etc.); medical treatments (chemotherapy, radiation, immune system-suppressing drugs, etc.); workplace exposures; household exposures; pollution; and lifestyle factors. The Strategy and Implementation Plan for the International Agency for Research on Cancer (IARC) states that, “The environment (defined in its broadest sense to include lifestyle, nutrition and occupation, in addition to physical, chemical and biological factors), plays a role in the overwhelming majority of cancers and consequently, at least in principle, the majority can be prevented. However, despite advances in identifying a number of major human carcinogens there remain a significant proportion of cancers for which the etiology is unclear.”

In 2003 the Breast Cancer and the Environment Research Program (BCERP), a joint effort funded by National Institute of Environmental Health Sciences (NIEHS) and the National Cancer Institute began studying the impact of prenatal-to-adult environmental exposures that might predispose a woman to breast cancer. NIEHS concludes that, “Most experts agree that breast cancer is caused by a combination of genetic, hormonal, and environmental factors.” After seven years of research the NIEHS stated: “Reports are already pointing to weak relationships between exposure to these endocrine disruptors and the early onset of puberty. This factor may be one of the pieces in the complex puzzle that alters risk of breast cancer. Further studies are under way within the BCERP to understand the impact of indoor pesticides, heavy metals, diet, pregnancy, and hormone-like substances found in cosmetics and sunscreen.” The largest state-funded research effort in the nation, the California Breast Cancer Research Program, was established in 1993 also based on the premise that environmental factors play an important role in cancer development.

Community-based organizations such as the Silent Spring Institute founded in 1993 also argue that the rise in breast cancer incidence is not surprising given the amount of synthetic chemicals that entered the marketplace after World War II, which contain chemical carcinogens known to damage DNA, promote tumor growth, and increase the carcinogenic susceptibility of mammary glands. The Breast Cancer Fund‘s seminal report, State of the Evidence (now in its 6th edition), continually reviews the body of research about the timing of toxic exposures, low-dose exposures at environmentally significant levels, real-life mixtures of exposures; and the complexity of interactions between environmental and other risk factors for breast cancer. Incidentally, the NIEHS links to the Breast Cancer Fund’s State of the Evidence report on its web page as a key resource.

Let it be confirmed: There is a body of evidence suggesting environmental links to breast cancer. At the same time, toxic exposures do not usually cause disease single-handedly, save for intense acute exposures. What’s more likely is that there is a delicate balance among exposures over time, accumulated genetic changes resulting from exposures, protective factors, susceptibility, disease heterogeneity, and differing mechanisms of action brought upon by chemical compounds. Together, these set the conditions, or not, for cancer. The mechanisms are not clear cut. What is clear, however, is that the environment matters.

Despite the body of knowledge and the vast amount of ongoing scientific research to hone in on environmental links to cancer, the IOM report is concerning in several ways, including the fact that the report focuses on a definition of the environment that is much too broad (i.e., all factors that are not directly inherited through DNA, p. 1-4), with a strong emphasis on lifestyle factors as environmental. It also downplays the dangers of industrial chemicals (i.e., those that are biological plausible, but not causally confirmed in humans, p. 3-4), fails to stress precautionary principles when dealing with toxic substances that are implicated in the development of breast cancer (e.g., endocrine disruptors, p. 3-36), and puts too much emphasis on the weighty, but contradictory message that women should “take action” to reduce their breast cancer risk even though the report emphasizes that, “based on the existing literature…it [is] difficult to estimate the magnitude of the potential impact of these actions for either individuals or population groups.” (p. 6-19).

The report is also confusing when it comes to the future of environmental cancer research. It identifies key areas of study, such as circadian rhythm, endocrine activity and interactions between chemicals (e.g., BPA and other suspect culprits), the degree to which chemicals known to mutate genes (such as polycyclic aromatic hydrocarbons (PAHs), benzene, and ethylene oxide) contribute to breast cancer risk, and the potential importance of environmental chemicals (such as BPA) that change how genes function. Studies are already underway in these areas and yes, more are needed. At the same time, the report emphasizes seemingly insurmountable barriers to such research:

“Tracing multiple and potentially interacting causes of breast cancer will be difficult. Some risk factors may have very weak effects or effects in only a small portion of the population, making their contribution to risk hard to detect. People are exposed to a complex and changing mix of environmental agents over the course of a lifetime; discerning the effects of an individual agent, or knowing whether the components of the mixture may interact to influence the development of disease, is not straightforward. Moreover, many of these agents have never been studied in ways that could indicate whether they might be relevant to breast cancer. Several challenges appear especially formidable.” (IOM Summary, p. S-5)

Looks like we’re back to square one. Individuals should focus on what they can do: don’t smoke, exercise, eat right, avoid too much alcohol, try not to disrupt your hormones, don’t have too many x-rays…all good advice…and…you still might get breast cancer. Is this really all that can be done in the face of mounting environmental evidence, increasing breast cancer incidence (particularly those involving estrogen), and an average 40,000 deaths per year?

Jeannie Rizzo of The Breast Cancer Fund told Forbes that, “The failure to take a precautionary approach may leave the public confused and even misinformed, as is evidenced by some of the initial media headlines about the report that say that chemicals are unproven to raise breast cancer risk, when the report itself indicated there are plausible reasons for concern.” Similarly, Karuna Jaggar of Breast Cancer Action told USA Today that, “Waiting for absolute proof is killing us. We need to take steps now to prevent women from being exposed to chemicals that increase their risk of breast cancer.” I agree. If women are routinely charged with the responsibility of knowing their risk and taking proactive steps to reduce it, why shouldn’t society be held to the same standard?

If you’re interested in hearing a discussion of the IOM report and its implications with some notable scientists, the Collaborative on Health and the Environment (CHE) — an international partnership committed to strengthening the scientific and public dialogue on environmental factors linked to chronic disease and disability — will be holding a partnership call on December 16, 2011 at 10:00 am Pacific / 1 pm Eastern. Featured speakers will include: (1) Suzanne Fenton, PhD, Reproductive Endocrinologist, Cellular and Molecular Pathology Branch, National Toxicology Program, NIEHS; (2) Peggy Reynolds, PhD, MPH, Senior Research Scientist, Cancer Prevention Institute of California; (3) Richard Clapp, DSc, MPH, Professor of Environmental Health, Boston University School of Public Health; and (4) Ted Schettler, MD, MPH, Science Director, Science and Environmental Health Network (SEHN) and CHE. The call will be moderated by Steve Heilig, San Francisco Medical Society and CHE. The call will last one hour and will be recorded for archival purposes. Go here for more information.

Additional Resources (alphabetical listing):

Asturias Declaration: A Call for Action (2011) – The International Agency for Research on Cancer (IARC) supports and endorses the Asturias Declaration, which calls for the primary prevention of environmental and occupational cancer in countries around the world. IARC scientists worked closely together with colleagues at World Health Organization to develop the scientific programme and to draft the Asturias declaration, a call for action.

Consensus Statement on Breast Cancer and the Environment (Breast Cancer Working Group of the Collaborative on Health and the Environment, 2006) – Concludes that research has made clear that breast cancer and other cancers result from a complex web of causation in which multiple factors interact.

Disease Clusters Spotlight the Need to Protect People from Toxic Chemicals (by Kathleen Navarro, Sarah Janssen, MD, PhD, MPH, Terry Nordbrock, MLS, MPH, Gina Solomon, MD, MPH) – An unusually large number of people sickened by a disease in a certain place and time is known as a ‘disease cluster’. Clusters of cancer, birth defects, and other chronic illnesses have sometimes been linked to chemicals or other toxic pollutants in local communities, although these links can be controversial. There is a need for better documentation and investigation of disease clusters to identify and address possible causes. Published by the Natural Resources Defense Council.

Identifying Gaps in Breast Cancer Research (Julia G. Brody, PhD, Marion H.E. Kavanaugh-Lynch, MD, MPH , Olufunmilayo I Olopade, MD, Walter L. Palmer Distinguished Service Professor of Medicine, Susan Matsuko Shinagawa, Sandra Steingraber, PhD, David R. Williams, PhD, 2007) – a review of existing research—gathered from widely scattered sources—pointed toward discovering research areas that show some connection with the disease, and recommending further investigations that are likely to make the most difference toward eliminating the death and suffering caused by breast cancer. Published by the California Breast Cancer Research Program Special Research Initiatives.

International Agency for Research on Cancer (IARC) Medium-Term Strategy and Implementation Plan for 2010–2014 (2010) – Identifies how the IARC must orientate its activities over the next two decades such that it can best contribute to combating the projected increase in the global cancer burden.

National Institute of Environmental Health Sciences (NIEHS) Environmental Factors and Breast Cancer Risk – Briefly outlines the Institutes efforts to research the interplay of genetic, hormonal, and environment factors in increasing breast cancer risk, including the landmark Sister Study of 50,000 healthy sisters of women diagnosed with breast cancer, the impact of family history (e.g., the BRCA1 gene), cancer causing chemicals and exposures, research centers focusing on breast cancer and the environment, and the role of artificial light.

National Toxicology Program Report on Carcinogens (12th Edition, 2011) – U.S. Department of Health and Human Services Secretary Kathleen Sebelius released the 12th Report on Carcinogens on June 10, 2011. The Report on Carcinogens (RoC) is a congressionally mandated, science-based, public health document that is prepared for the HHS Secretary by the National Toxicology Program. The report identifies agents, substances, mixtures, and exposure circumstances that are known or reasonably anticipated to cause cancer in humans.

Pathways to Breast Cancer: A Case Study for Innovation in Chemical Safety Evaluation (by Megan Schwarzman, MD, MPH and Sarah Janssen, MD, PhD, MPH, 2010) – Drawing on the fields of cancer biology, toxicology, medicine, epidemiology, public health, and public policy, a multidisciplinary expert panel reviewed existing methods for chemical toxicity testing and developed a testing scheme, called the Hazard Identification Approach. This approach provides a methodology for the identification of substances that could elevate breast cancer risk.

State of the Evidence: The Connection Between Breast Cancer and the Environment (by Janet Gray, PhD, 2010) – The sixth edition of the Breast Cancer Fund’s signature report examining the scientific evidence linking exposures to environmental chemicals and radiation with breast cancer. In this edition, the evidence is placed in a larger conceptual context, with a substantial discussion of framing themes and methodological issues with new evidence cited in almost all categories of exposures covered.

The Falling Age of Puberty in U.S. Girls: What We Know, What We Need to Know (by Sandra Steingraber, PhD 2007) – This report is a review of the published literature on the timing of puberty in U.S. girls. It describes the basic biology of puberty, identifies the various determinants that seem to influence its onset and explores their possible interactions. Early puberty—in particular, early menarche—is a known risk factor for breast cancer. Ongoing ignorance about the extent to which chemical exposures are altering the timing of sexual maturation in children is directly attributable to a lack of basic data on the ability of common chemicals to act as endocrine disruptors.

Be Sociable, Share!

3 comments to Breast Cancer and the Environment – Report from the IOM

  • Thank you for this important response to the IoM’s report, Gayle. I’m most interested by what you point to within the document’s rhetoric–the continued shaming of women for their breast cancers (or diseases in general). I’m reminded of Susan Yandlon’s work on this issue. If we ladies could just take some responsibility for our health, lose some weight, or have babies sooner, maybe we wouldn’t have breast cancer. Ugh.

  • Interestingly, the same day that the I heard about the IOM findings being presented at the San Antonio Breast Cancer Symposium, I received an email notice about this latest blog post by The Ethical Nag, “Be suspicious of research presented at scientific meetings,” Different meeting, different research topic addressed, but an apt message nonetheless. The general theme of the post is that we should beware of the media hype attached to so-called ‘breakthrough’ study findings announced at these meetings. Often, the studies are preliminary, or not well-designed, or have not yet gone through the peer-review process required for publication in a journal. In other words, all too often, such findings are much ado about nothing. Hmm. Once again, we are all well-advised to look behind the headlines and place such reports into a larger context, as you have so ably done here. While repetition is one of the cornerstones of establishing credibility in research, was the million dollars spent to fund the IOM findings which in fact appear to be only a rehash of old news really money well spent? I think not.

  • “Women may have some opportunities to reduce their risk of breast cancer through personal actions…” Sounds like the report is blaming women for having breast cancer. I’m really tired of the media blitzkrieg on all the factors that cause cancer. It’s the same old broken record.

    Thank you for an enlightening post and sharing your opinion on the report.

"women urged to get screened because it might save their lives. But that’s only 1 possible outcome, and it’s the least likely one" @cragcrest

“Pink Ribbon Blues”

Paperback includes a new Introduction on fundraising controversies and a color insert with images of, and reactions to, the pinking of breast cancer (2012).

Praise » 

Flyer »

Press Release »

Hardback Cover »

Paperback Cover »

Request Review Copies »

Order the Paperback »


"Seeing clearly through the pink haze" Toronto Sun

*Sad face*: Being happy does not help you live longer" New Scientist

How should we address breast cancer when norms continually change? The Guardian

Your Fun 'No Bra Day' Photos Are Overshadowing Terminal Breast Cancer Patients Broadly

Backlash against “pinkwashing” of breast cancer awareness campaigns BMJ

Breast Cancer to Rise 50 Percent by 2030? Hey, Not So Fast! Health News Review

Breast Cancer: The Flaws in the Cause

How to Make the Biggest Impact With Your Breast Cancer Donations Money

The Very Pink, Very Controversial Business of Breast Cancer Awareness Racked

NFL, Pink Ribbons Not Enough to Win over Women CNN

3 Questions We Need to Answer for Breast Cancer Awareness Month Chronicle of Philanthropy

The problem with National Breast Cancer Awareness Month Women's Health Magazine

Pink Ribbon Envy: Living with an Uncool Cancer The Nib

A Year After Bombings, Some Say 'Boston Strong' Has Gone Overboard NPR, All Things Considered

Canadian Mammogram Study KCRW, NPR Affiliate

Time to Debunk the Mammography Myth CNN

Breast Cancer: Awareness, Activism & Pinkwashing NPR Charlotte

Buying Pink Al Jazeera's The Stream Watch »

The Pink Backlash Orlando Sentinel

Why Jolie's Test Costs So Much CNN

Preventative Mastectomies: Disease and Deception BlogTalkRadio

Angelina Jolie and the 'Breast Cancer Gene' KCRW

Our Feel-Good War on Breast Cancer The New York Times Magazine.

The Story Behind the Pink Ribbon Campaign Sisters Talk Radio

WISH Interview Women's International Summit for Health

Making Cancer About The Patient, Not The Body Part CBS Pittsburgh

Sexy breast cancer campaigns anger many patients USA Today

The perils of pink The Daily

Komen pink campaign creates breast-cancer blues for some Dallas Morning News

A yellow flag for the NFL's pink New York Daily

Gayle Sulik named #7 in SharecareNow’s Top 10 Online Influencers in Breast Cancer

Breast cancer cancer causes so easily derailed Philly Inquirer

Komen Charity Under Microscope for Funding, Science Reuters

The Fight Against Cancer - And Abortion?

Susan G. Komen For the Cure defunds Planned Parenthood. In Deep with Angie Coiro

Amid Breast Cancer Month, Is there Pink Fatigue? NPR's All Things Considered

How is Breast Cancer Culture Undermining Women's Health? America’s Radio News Network

Pink Ribbon Culture and Breast Cancer The Kojo Nnamdi Show

The Big Business of Breast Cancer
Marie Claire

Does Breast Cancer Awareness Month Crowd Out Other Diseases? Slate

Pink Inc. Has Many Starting to See Red The Sacramento Bee

Get Your Pink Off Ottawa Citizen

Komen Pink Ribbons Raise Green and Questions USA Today